United States · FDA National Drug Code directory
Cetirizine Hydrochloride Tablets,10 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49483-692_12f9d89b-5334-1339-e063-6394a90ad0e8
- Product NDC
- 49483-692
- Form
- TABLET
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- TIME CAP LABORATORIES, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220212
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (49483-692-01) · 49483-692-01
- 200 TABLET in 1 BOTTLE (49483-692-20) · 49483-692-20
- 500 TABLET in 1 BOTTLE (49483-692-50) · 49483-692-50
- 365 TABLET in 1 BOTTLE (49483-692-65) · 49483-692-65
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →